Tag: Hatch-Waxman
Why the First Generic Filer Gets 180-Day Exclusivity in the U.S. Drug Market
15 Dec
|
11:52 AM
The first generic drug company to file a patent challenge gets 180 days of exclusive sales rights. But this rule, meant to lower drug prices, is often manipulated-delaying competition and keeping patients from affordable medicines.
read more
